aintenance of weight loss, in patients who are obese or overweight with co-morbidities such as hypertension, type 2 diabetes, dyslipidemia or central adiposity. [08:11] {Threei} BofA/Merrill Lynch cutting Q4 EPS est to $5.74 from $6.57 (prior); Cuts MS Q4 EPS est to $0.40 from $0.47 (prior) [08:11] {Threei} - Firm is cutting JPM Q4 EPS est to $0.68 from $0.71 [08:11] {Threei} - Firm maintains C Q4